Recent Advances in Nanotechnology-Based Formulations for Curcumin Delivery

Sachin Sharma¹ , R.K. Roy²

1. Master of Pharmacy, H.R. Institute of Pharmacy, Morta, Ghaziabad, Uttar Pradesh, India.
2. H.R. Institute of Pharmacy, Morta, Ghaziabad, Uttar Pradesh, India.

Section:Review Paper, Product Type: Journal-Paper
Vol.10 , Issue.3 , pp.45-52, Mar-2024

Online published on Mar 31, 2024

Copyright © Sachin Sharma, R.K. Roy . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

50 Views    34 Downloads    4 Downloads

Abstract :
Curcumin, extracted from the turmeric plant, demonstrates notable therapeutic potential such as anti-inflammatory, antioxidant, and anticancer properties. Nonetheless, its clinical utility is hindered by limited bioavailability. In recent years, nanotechnology-based formulations have emerged as a transformative approach to address this challenge and enhance the delivery of curcumin. This review provides a comprehensive overview of recent advances in nanotechnology-based formulations for curcumin delivery. The first section delves into various nanoparticle formulations, including liposomes, polymeric nanoparticles, and micelles, highlighting their structures and discussing advantages and limitations in curcumin delivery. The subsequent section focuses on transferosomes, emphasizing their unique characteristics in facilitating transdermal curcumin delivery. Additionally, the review explores combination therapies involving curcumin and other agents within nanocarrier systems, such as the synergistic effects observed with piperine. Targeted delivery systems represent another key aspect, with an examination of recent developments in delivering curcumin to specific tissues or cells using nanocarriers. Surface modifications, designed to enhance the stability and bioavailability of curcumin-loaded nanocarriers, are discussed in a dedicated section. Furthermore, the potential and challenges of intranasal delivery for curcumin using nanotechnology-based formulations are explored. The review concludes by addressing current challenges in the clinical translation of nanotechnology-based curcumin formulations and proposing future perspectives for advancing this field. The integration of nanotechnology into curcumin delivery holds significant promise for unlocking the full therapeutic potential of this natural compound.

Key-Words / Index Term :
Curcumin, Nanotechnology, Drug Delivery, Transferosomes, Combination Therapy

References :
[1] B. B. Aggarwal, C. Sundaram, N. Malani, H. Ichikawa, "Curcumin: the Indian solid gold," The molecular targets and therapeutic uses of curcumin in health and disease, Vol.4, no.6, pp.807-818, 2007.
[2] P. Anand, A. B. Kunnumakkara, R. A. Newman, B. B. Aggarwal, "Bioavailability of curcumin: problems and promises," Molecular pharmaceutics, Vol.4, no.6, pp.807-818, 2007.
[3] O. C. Farokhzad, R. Langer, "Impact of nanotechnology on drug delivery," ACS nano, Vol.3, no.1, pp.16-20, 2009.
[4] P. Anand, H. B. Nair, B. Sung, A. B. Kunnumakkara, V. R. Yadav, R. R. Tekmal, B. B. Aggarwal, "Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo," Biochemical pharmacology, Vol.79, no.3, pp.330-338, 2010.
[5] S. Bisht, M. Mizuma, G. Feldmann, N. A. Ottenhof, S. M. Hong, D. Pramanik, A. Maitra, "Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer," Molecular cancer therapeutics, Vol.8, no.3, pp.744-754, 2009.
[6] M. M. Yallapu, M. Jaggi, S. C. Chauhan, "Curcumin nanoformulations: a future nanomedicine for cancer," Drug discovery today, Vol.17, no.1-2, pp.71-80, 2012.
[7] G. Cevc, G. Blume, "Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force," Biochimica et Biophysica Acta (BBA)-Biomembranes, Vol.1104, no.1, pp.226-232, 1992.
[8] P. Verma, K. Pathak, D. Pathak, "Aerodynamic assessment of celecoxib-loaded nanostructured lipid carriers produced by different methods employing dry powder inhaler," AAPS PharmSciTech, Vol.11, no.4, pp.1332-1344, 2010.
[9] E. Touitou, B. Godin, Y. K. Karl, "Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties," Journal of Controlled Release, Vol.113, no.3, pp.212-218, 2006.
[10] G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, P. S. Srinivas, "Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers," Planta medica, Vol.64, no.4, pp.353-356, 1998.
[11] J. Shaikh, D. D. Ankola, V. Beniwal, D. Singh, M. N. Kumar, "Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer," European journal of pharmaceutical sciences, Vol.37, no.3-4, pp.223-230, 2009.
[12] H. Hu, X. Yang, Y. Qin, Y. Zhu, X. Wang, "The role of piperine in increasing the bioavailability of nutrients and bioactive compounds," Molecular Nutrition, pp.173-183, Springer, 2015.
[13] Patil, V. H. Goud, "An updated review on therapeutic potential of piperine combined with other bioactive components," Fitoterapia, Vol.134, pp.76-87, 2019.
[14] Y. Wang, J. Chen, J. Irudayaraj, Y. Shen, "A pH-triggered, fast-responding DNA hydrogel," Angewandte Chemie International Edition, Vol.57, no. 21, pp.6230-6234, 2018.
[15] Sahu, N. Kasoju, U. Bora, P. Goswami, "Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells," Acta Biomaterialia, Vol.4, no. 6, pp.1752-1761, 2008.
[16] Xiao, L. Ma, D. Merlin, K. Nan, "The promising role of nanocarriers in enhancing the bioavailability and therapeutic efficacy of ellagic acid," International Journal of Pharmaceutics, Vol.570, pp.118642, 2019.
[17] T. M. Allen, P. R. Cullis, "Drug delivery systems: entering the mainstream," International Journal of Scientific Research in Multidisciplinary Science, Vol.303, no.5665, pp.1818-1822, 2004.
[18] F. Kratz, "Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles," Journal of Controlled Release, Vol. 132, no.3, pp.171-183, 2008.
[19] Q. He, J. Shi, "Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility," Journal of Materials Chemistry, Vol. 20, no. 40, pp. 7599-7602, 2010.
[20] U. Bulbake, S. Doppalapudi, N. Kommineni, W. Khan, "Liposomal formulations in clinical use: an updated review," Pharmaceutics, Vol. 9, no. 2, pp. 12, 2017.
[21] S. Mura, J. Nicolas, P. Couvreur, "Stimuli-responsive nanocarriers for drug delivery," Nature materials, Vol.12, no.11, pp. 991-1003, 2013.
[22] Xiao, B., Ma, L., Merlin, D., & Nan, K. (2019). The promising role of nanocarriers in enhancing the bioavailability and therapeutic efficacy of ellagic acid. International Journal of Pharmaceutics, Vol.570, pp.118642, 2019.
[23] Allen, T. M., & Cullis, P. R. (2004). Drug delivery systems: entering the mainstream. International Journal of Scientific Research in Multidisciplinary Science, Vol. 303, Issue 5665, pp.1818-1822, 2004.
[24] Kratz, F. (2008). Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. Journal of Controlled Release, Vol.132, Issue.3, pp.171-183, 2008.
[25] He, Q., & Shi, J. (2010). Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. Journal of Materials Chemistry, Vol.20, Issue.40, pp.7599-7602, 2010.
[26] Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017). Liposomal formulations in clinical use: an updated review. Pharmaceutics, Vol. 9, Issue.2, pp.12, 2017.
[27] Mura, S., Nicolas, J., & Couvreur, P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nature materials, Vol.12, Issue.11, pp. 991-1003, 2013.